I joined Novartis in 2026 as a Principal Biostatistician and based in New Jersey USA, supporting New Drug Application (NDA) and other regulatory submissions of clinical trials. Prior to this, I worked as a Senior Biostatistician at Edwards Lifesciences for two years, where I mainly worked on clinical trials of cardiovascular medical device. Before starting my industry jobs, I completed the dual degree of both engineering and statistics at the University of Illinois Urbana-Champaign in 2020, and then obtained the doctorate degree of biostatistics from the University of Texas MD Anderson Cancer Center in 2023.